Advertisement

AAAAI: Omalizumab Superior to Placebo for Those With Multiple Food Allergies

0

16 weeks of omalizumab superior for increasing reaction threshold for peanut and other food allergens

Fine Particulate Matter Levels Below WHO Guidelines Tied to Hospital Admission

0

Studies show increased relative risk for admission for composite CVD and increased risk for admission for natural causes

Level of Burnout Higher for Women in Health Care Occupations

0

Gender-specific factors that have direct link to well-being include job satisfaction, psychological health, and work-life integration

Jill Biden Announces $100 Million for Research on Women’s Health

0
By Robin Foster HealthDay Reporter THURSDAY. Feb. 22, 2024 (HealthDay News) -- First Lady Jill Biden on Wednesday announced $100 million in federal funding to...

This Election Year, Health Care Costs Top Voter Concerns: Poll

0
By Dennis Thompson HealthDay Reporter WEDNESDAY, Feb. 21, 2024 (HealthDay News) -- Unexpected medical bills and high health care costs are dominating an election where...

Expanded Use of Xolair to Treat Food Allergies Approved by the FDA

0

Xolair is not meant to substitute for emergency anaphylaxis medications such as the EpiPen

Phenylephrine Sales Sizeable and Steady Despite Efficacy Concerns

0

Most phenylephrine products are coformulated with antihistamines or antitussives

Asthma More Common Among Youth Reporting Cannabis Use

0

Findings suggest a dose-response relationship

Price of Prescription Drugs Almost Threefold Higher in the United States

0

U.S. prices for brand-name originator drugs 422 percent higher; price of unbranded generics 67 percent of comparison countries

Exhalation Delivery System With Fluticasone Effective for Rhinosinusitis

0

EDS-FLU improved symptoms, sinus opacification, acute exacerbations in two randomized trials in adults with chronic rhinosinusitis